The 44 references in paper N. Tsareva A., Н. Царева А. (2017) “Идиопатическая легочная артериальная гипертензия: современный подход к диагностике и лекарственной терапии // Idiopathic pulmonary arterial hypertension: current approach to diagnosis and pharmacological treatment” / spz:neicon:pulmonology:y:2017:i:2:p:216-231

1
GaliéN., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J.2009; 34 (6): 1219–1263. DOI: 10.1183/ 09031936. 00139009.
(check this in PDF content)
2
Чазова И.Е., Мартынюк Т.В., ред. Легочная гипертензия. М.: Практика; 2015.
(check this in PDF content)
3
Vachiery J.-L., Gaine S. Challenges in the diagnosis and treatment of pulmonary arterial hypertension.Eur. Respir. Rev. 2012; 21 (126): 313–320. DOI: 10.1183/09059180. 00005412.
(check this in PDF content)
4
Chemla D., Castelain V., HervéP. et al. Haemodynamic evaluation of pulmonary hypertension.Eur. Respir. J.2002; 20 (5): 1314–1331. DOI: 10.1183/09031936.02.00068002.
(check this in PDF content)
5
Benza R.L., Miller D.P., Gomberg-Maitland M. et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010; 122 (2): 164–172. DOI: 10.1161/CIRCULATIONAHA.109.898122.
(check this in PDF content)
6
Badesch B.D., Champion H.C., Gomez-Sanchez M.A. et al. Diagnosis and assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol.2009; 54 (30): S55–S56. DOI: 10.1016/ j.jacc.2009.04.011.
(check this in PDF content)
7
Berger R.M., Beghetti M., Humpl T. et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012; 379 (9815): 537–546. DOI: 10.1016/S0140-6736(11) 61621-8.
(check this in PDF content)
8
Trulock E., Edwards L., Taylor D. et al. Registry of the International Society for Heart and Lung Transplantation twenty fourth official adult lung and heart lung transplantation report 2007. J. Heart Lung Transplant.2007; 26 (8): 782–795. DOI: 10.1016/j.healun.2007.06.003.
(check this in PDF content)
9
Stehlik J., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report–2010.J. Heart Lung Transplant.2010; 29 (10): 1089– 1103. DOI: 10.1016/j.healun.2010.08.007.
(check this in PDF content)
10
Sitbon O., Morrell N.W. Pathways in pulmonary arterial hypertension: the future is here. Eur. Respir. Rev. 2012; 21 (126): 321–327. DOI: 10.1183/09059180.00004812.
(check this in PDF content)
11
Solomon J.J., Olson A.L., Fischer A. et al. Scleroderma lung disease.Eur. Respir. Rev.2013; 22 (127): 6–19. DOI: 10.1183/ 09059180.00005512.
(check this in PDF content)
12
Guazzi M., GaliéN. Pulmonary hypertension in left heart disease. Eur. Respir. Rev. 2012; 21 (126): 338–346. DOI: 10.1183/ 09059180.00004612.
(check this in PDF content)
13
Diller G.P., Dimopoulos K., Okonko D. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112 (8): 828–835. DOI: 10.1161/CIRCULATIONAHA.104.529800.
(check this in PDF content)
14
Peacock A.J., Murphy N.F., McMurray J.J.V. et al. An epidemiological study of pulmonary arterial hypertension. Eur. Respir. J.2007; 30 (1): 104–109. DOI: 10.1183/09031936. 0009 2306.
(check this in PDF content)
15
GaliéN., Palazzini M., Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur. Heart J. 2010; 31 (1): 2080–2086. DOI: 10.1093/eurheartj/ehq152.
(check this in PDF content)
16
Michelakis E.D. The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension. Heart Fail. Rev. 2003; 8 (1): 5–21. DOI: 10.1023/A:1022150819223.
(check this in PDF content)
17
Rubin L.J., Simonneau G., Badesch D. et al. The study of risk in pulmonary arterial hypertension.Eur. Respir. Rev. 2012; 21 (125): 234–238. DOI: 10.1183/09059180. 00003712.
(check this in PDF content)
18
Humbert M., Souza R., Galie N. et al. Pulmonary arterial hypertension: bridging the present to the future.Eur. Respir. Rev.2012; 21 (126): 267–270. DOI: 10.1183/09059180. 00005312.
(check this in PDF content)
19
Simonneau G., Gatzolis G., Adatia I. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62 (25, Suppl.): D35–D41. DOI: 10.1016/j.jacc. 2013.10.029.
(check this in PDF content)
20
Humbert M., Sitbon O., Yaici A. et al. Survival in incident and prevalent cohort of patients with pulmonary arterial hypertension.Eur. Respir. J. 2010; 36 (3): 549–555. DOI: 10.1183/ 09031936.00057010.
(check this in PDF content)
21
GaliéN., Hoeper M., Torbicki A. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur. Heart J. 2009; 30 (20): 2493– 2537. DOI: 10.1093/eurheartj/ehr046.
(check this in PDF content)
22
Nickel N., Golpon H., Greer M. et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.Eur. Respir. J.2012; 39 (3): 589–596. DOI: 10.1183/09031936.00092311.
(check this in PDF content)
23
Soubrier F., Chung W.K., Machado R. et al. Genetics and genomics of pulmonary arterial hypertension.J. Am. Coll. Cardiol. 2013; 62 (25, Suppl.): D13–D21. DOI: 10.1016/j.jacc. 2013.10.035.
(check this in PDF content)
24
Eyries M., Montani D., Girerd B. et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.Nat. Genet. 2014; 46 (1): 65–69. DOI: 10.1038/ng.2844.
(check this in PDF content)
25
D’Alto M., Mahadevan V.S. Pulmonary arterial hypertension associated with congenital heart disease. Eur. Respir. Rev. 2012; 21(126): 328–337. DOI: 10.1183/09059180. 00004712.
(check this in PDF content)
26
Huang J.B., Liang J., Zhou L.Y. Eisenmenger Syndrome: Not Always Inoperable. Respir. Care.2012; 57 (9): 1488–1495. DOI: 10.4187/respcare.01418.
(check this in PDF content)
27
Rubin L.J. Primary pulmonary hypertension. Chest. 1993; 104 (1): 236–250.
(check this in PDF content)
28
Rubin L.J., Badesch D.B. Evaluation and management of the patient with pulmonary arterial hypertension. Ann. Intern. Med. 2005; 143 (4): 282–292. DOI: 10.7326/0003-4819-143-4200508160-00009.
(check this in PDF content)
29
GaliéN., Rubin L.J. Introduction: new insights into a challenging disease: A review of the third world symposium on pulПульмонология. 2017; 27 (2): 216–231. DOI: 10.18093/086930189320173273232163231 monary arterial hypertension. Am. Coll. Cardiol. J. 2004; 43 (12): S1. DOI: 10.1016/j.jacc.2004.03.003. 45. McGoon M.D. The assessment of pulmonary hypertension. Clin. Chest Med.2001; 22 (3): 493–508. 46. McLaughlin V.V., McGoon M.D. Pulmonary arterial hypertension. Circulation.2006; 114 (13): 1417–1431. DOI: 10.1161/ CIRCULATIONAHA.104.503540. 47. Trip P., Nossent E.J., de Man F.S. et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur. Respir. J. 2013; 42 (6): 1575
(check this in PDF content)
30
GaliéN., Torbicki A., Barst R. et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur. Heart. J. 2004; 25 (24): 2243–2278. DOI: 10.1016/ j.ehj.2004. 09.014.
(check this in PDF content)
31
Hambly N., Alawfi F., Mehta S. Pulmonary hypertension: diagnostic approach and optimal management. CMAJ. 2016; 188 (11): 804–812. DOI: 10.1503/cmaj.151075.
(check this in PDF content)
32
McLaughlin V.V., Archer S.L., Badesch D.B. et al. ACCF/ AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009; 119 (16): 2250–2294. DOI: 10.1161/CIRCULATIONAHA. 109.192230.
(check this in PDF content)
33
Чазова И.Е., Жданов В.С., Веселова С.П., Мареев В.Ю. Патология первичной легочной гипертензии. Архив патологии. 1993; (3): 52–55.0
(check this in PDF content)
34
Lowe B.S., Therrien J., Ionescu-Ittu R. et al. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes.J. Am. Coll. Cardiol. 2011; 58 (5): 538–546. DOI: 10.1016/j.jacc.2011.03.033.
(check this in PDF content)
35
Raymond R.J., Hinderliter A.L., Willis P.W. et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.J. Am. Coll. Cardiol. 2002; 39 (7): 1214–1219.
(check this in PDF content)
36
Humbert M., Sitbon O., Chaouat A. et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation.2010; 122 (2): 156–163. DOI: 10.1161/CIRCULATIONAHA.109.911818.
(check this in PDF content)
37
Humbert M., Sitbon O., Yaici A. et al. Survival in incident and prevalent cohort of patients with pulmonary arterial hypertension. Eur. Respir. J.2010; 36 (3): 549–555. DOI: 10.1183/ 09031936.00057010.
(check this in PDF content)
38
Stenmark K.R., Davie N., Frid M. et al. Role of the adventitia in pulmonary vascular remodeling. Physiology(Bethesda). 2006; 21 (2): 134–145. DOI: 10.1152/physiol. 00053.2005.
(check this in PDF content)
39
Tuber R.M., Cool C.D., Yeager M. et al. The pathobiology of pulmonary hypertension. Endothelium. Clin. Chest Med.2001; 22 (3): 405–418.
(check this in PDF content)
40
Gossage J.R., Christman B.W. Mediators of acute and chronic pulmonary hypertension.Semin. Respir. Crit. Care Med. 1994; 15 (4): 453–462.
(check this in PDF content)
41
GaliéN., Manes A., Branzi A. New insights on pulmonary arterial hypertension. Rev. Esp. Cardiol.2004; 57 (7): 603– 607. DOI: 10.1016/S1885-5857(06)60282-X.
(check this in PDF content)
42
Duong-Quy S. Physiopathology of pulmonary hypertension: from bio-molecular mechanism to target treatment. J. Vasc. Med. Surg. 2016; 22 (4): 294–299. DOI: 10.4172/2329-6925. 1000294.
(check this in PDF content)
43
Duplain H., Burcelin R., Sartori C. et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001; 104 (3): 342–345. DOI: 10.1161/01.CIR.104.3.342.
(check this in PDF content)
44
Barst R.J., McGoon M., Torbicki A. et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol.2004; 43 (12, Suppl.): S40–S47. DOI: 10.1016/ j.jacc.2004.02.032. http:// journal.pulmonology.ru/pulm
(check this in PDF content)